← Product Code [PHP](/productcode/PHP) · P250029

# SimpleScreen™ CRC (P250029)

_Freenome, LLC · PHP · Jul 24, 2026 · APPR_

**Canonical URL:** https://fda.innolitics.com/device/P250029

## Device Facts

- **Applicant:** Freenome, LLC
- **Product Code:** [PHP](/productcode/PHP.md)
- **Decision Date:** Jul 24, 2026
- **Decision:** APPR
- **Device Class:** Class 3

## Regulatory Identification

The colorectal neoplasia DNA methylation and hemoglobin detection system is a qualitative, non-invasive device used to screen for the detection of methylation of specific DNA markers associated with colorectal cancer and for the presence of occult hemoglobin in human specimens, including stool, blood, urine, and buccal swabs.  It is intended as an aid in the detection of colorectal cancer or advanced adenomas in conjunction with diagnostic colonoscopy.  It is indicated for use in adults 50 years or older, who are typical average-risk candidates for colorectal cancer (CRC) screening.

---

**Source:** [https://fda.innolitics.com/device/P250029](https://fda.innolitics.com/device/P250029)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a PMA](https://innolitics.com/services/regulatory/), [a 510(k)](https://innolitics.com/services/510ks/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com